Codexis to Report First Quarter 2026 Financial Results on May 7
REDWOOD CITY, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for...
Day: April 23, 2026
Tilray Brands Positioned for U.S. Expansion Amid Historic Cannabis Rescheduling
Tilray Medical Poised to Accelerate U.S. Medical Cannabis Access for PatientsNEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Tilray Brands,...
Ritedose, University of South Carolina Welcome Top European Business Students for Immersive Learning about Advanced Manufacturing
Ritedose University in Action Janisha Thomas, Chief Human Resources Officer at Ritedose, speaks to students from ESCP Business School at...
Nation’s Top Medical Equipment Rental Provider Expands to Portland as Oregon Hospitals Confront Nation’s Second-Tightest Bed Supply
US Med-Equip Adds Jobs and Opens Local Hub to Supply Oregon and Southwest Washington Health Systems With Rental Equipment Within...
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Real-World Example of Scientific Advancement Influence on Evaluation
NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement...
CytoDyn to Host Investor Webcast
VANCOUVER, Washington, April 23, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing...
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2026
SALT LAKE CITY, UT / ACCESS Newswire / April 23, 2026 / In the first calendar quarter (1Q) of 2026,...
Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026
CAMBRIDGE, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine...
ICU Medical Announces Time of First Quarter 2026 Earnings Conference Call
SAN CLEMENTE, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture...
Protagenic Therapeutics Appoints Industry Veteran Bill Nichols Jr. as President to Accelerate Advancement of First-in-Class TCAP Pathway Therapy PT00114
NEW YORK, NY / ACCESS Newswire / April 23, 2026 / Protagenic Therapeutics, Inc. (OTCQB:PTIX), a clinical-stage biopharmaceutical company pioneering...
SS Innovations Unveils Cutting-Edge Surgical Robotic Technologies at SMRSC 2026
Innovations under development by Company include the SSi Vimana Aero, SSi Avtara and SSi Operion A highlight reel of SS...
Manatee Appoints Dr. Neha Chaudhary, Harvard Child Psychiatrist and Pioneer in Digital Mental Health, to Board of Directors
DENVER, CO / ACCESS Newswire / April 23, 2026 / Manatee, a virtual provider of structured, whole-family mental health care,...
RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP™ Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting
Accepted Abstract is a Sub-Study in RenovoRx’s Ongoing Phase III TIGeR-PaC Clinical Trial and Explores the TAMP™ Therapy Platform’s Potential...
Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference
PARAMUS, NJ, April 23, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics (Nasdaq: PLYX), a clinical-stage biotechnology company focused on developing disease-modifying...
Enlivex to Present Phase IIa 3-month and 6-month Data of Allocetra at OARSI 2026 World Congress
Nes-Ziona, Israel, April 23, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, “Enlivex” or the “Company”), a quality longevity company...
2026 State of Digital Healthcare in Oncology Report Reveals Cancer Programs Are Rewiring Buying Around Speed to Treatment, Infusion Economics, and Precision Workflow – Black Book
New Black Book Research report, based on approximately 1,280 qualified U.S. oncology stakeholders, identifies the top-rated vendors across 16 oncology...
Moleculin’s Annamycin Extends Survival by More Than 60% in Metastatic Pancreatic Cancer Preclinical Models – Data Presented at AACR 2026
Non-cardiotoxic anthracycline demonstrates activity where traditional chemotherapies have historically failed, supporting potential expansion of Annamycin into a major unmet-need indication...
Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026
WALTHAM, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a commercial-stage biopharmaceutical company focused on the development...
Noom Health’s SmartRx Program on Track to Cut Employer’s GLP-1 Spend by Nearly 80%
Early data from first participating employer show that SmartRx can save organizations millions by bypassing traditional PBMs to deliver brand-name...
Collegium to Report First Quarter 2026 Financial Results on May 7, 2026
STOUGHTON, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that it will report first quarter...